1742-4690-6-33 1742-4690 Correction <p>Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors</p> Serrao Erik eserrao@usc.edu Odde Srinivas odde@usc.edu Ramkumar Kavya ramkumar@usc.edu Neamati Nouri neamati@usc.edu

Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, School of Pharmacy, 1985 Zonal Avenue, Los Angeles, CA 90089, USA

 Retrovirology 1742-4690 2009 6 1 33 http://www.retrovirology.com/content/6/1/33 10.1186/1742-4690-6-33 07 4 2009 08 4 2009 08 4 2009 2009 Serrao et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Correction to Erik Serrao, Srinivas Odde, Kavya Ramkumar and Nouri Neamati: Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors. Retrovirology 2009, 6:25. Since the recent publication of our article (Neamati, Retrovirology 2009, 6:25), we have noticed an error which we would like to correct and we would like to apologise to the readers for this mistake.

Correction

The structure of BMS-707035 has not been publicly released. In Figure one on page 2 and a discussion on page 5 of our published paper 1, we mistakenly assigned a structure and activity data to BMS-707035. The structure and activity data that we mentioned actually belong to a different compound from the same group. The resistance pattern of BMS-707035 is "overlapping" rather than identical to raltegravir. Please see the following references 23 for a detailed description of their development of pyrimidine carboxamides.

 <p>Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors</p> Serrao Erik Odde Srinivas Ramkumar Kavya Neamati Nouri Retrovirology 2009 6 25 2660292 19265512 10.1186/1742-4690-6-25 <p>Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors</p> Dicker IB Samanta HK Li Z Hong Y Tian Y Banville J Remillard RR Walker MA Langley DR Krystal M J Biol Chem 2007 282 43 31186 96 10.1074/jbc.M704935200 17715137 <p>Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors</p> Dicker IB Terry B Lin Z Li Z Bollini S Samanta HK Gali V Walker MA Krystal MR J Biol Chem 2008 283 35 23599 609 10.1074/jbc.M804213200 18577511